George K. Ross, Director at ACURA PHARMACEUTICALS, INC (ACUR), bought 50,000 shares at $0.10 ($5K) on 2017-12-14, disclosed to the SEC on 2017-12-18.
Open-market purchase of $5k ACUR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.